Debbie Rigby looks at the latest in research news Dapagliflozin: potential beneficial effects in the prevention and treatment of renal and cardiovascular complications in patients with type 2 diabetes This …

Debbie Rigby takes a look at the latest research news Factors associated with efficacy of an ibuprofen/pseudoephedrine combination drug in pharmacy customers with common cold symptoms The aim of this study …

Debbie Rigby rounds up the latest in research news pertinent to pharmacy Combined treatment with chondroitin sulfate and glucosamine sulfate shows no superiority over placebo for reduction of joint pain …

Debbie Rigby takes a look at the latest in research news Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain The American College of Physicians (ACP) have developed this …

Debbie Rigby takes a look at the latest in research news Association of SGLT-2 Inhibitors and Diabetic Ketoacidosis A US position statement on the prevalence of SGLT-2–associated DKA suggests that …

Debbie Rigby takes a look at the latest in research news Acid suppression medications and bacterial gastroenteritis A Scottish cohort study has use of proton pump inhibitors (PPIs) and H2 …

Debbie Rigby takes a look at the latest in research news Fall risk and anticoagulation for atrial fibrillation in the elderly Guidelines for managing atrial fibrillation recommend systemic anticoagulation for …

Debbie Rigby takes a look at the latest in research news Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes Evaluation Of patients in the ORBIT-AF II trial …

Debbie Rigby rounds up the latest in research news Optimizing identification and management of COPD patients – reviewing the role of the community pharmacist This paper proposes key steps for …

Debbie Rigby rounds up the latest in research news Pharmacist comprehensive review of treatment compared with STOPP-START criteria to detect potentially inappropriate prescription in older complex patients A prospective multicentre …

Debbie Rigby takes a look at the latest research news Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease In this large double-blind event-driven trial, ticagrelor (90 mg twice daily) was …

Debbie Rigby takes a look at the latest in research news Improving the Management of COPD in Women Chronic obstructive pulmonary disease (COPD) is a highly debilitating disease that represents …